Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
GlobeNewswire
*Recognition given for achievement in commercializing Joenja® (leniolisib), a first-in-class medication brought to market 10 years..